治疗的thalamic神经调节的进展:从机制到临床翻译
Jorge A Gonzalez-Martinez1, Arianna Damiani2, Joseph Parvizi3
1Departments of Neurological Surgery and Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Epilepsy currents
|March 16, 2026
概括
thalamic神经调节是一种有前途的治疗方法. 有效的策略需要基于大脑网络和电生理学的个性化准,超越一刀切的方法.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 生物医学工程 生物医学工程
背景情况:
- thalamic神经调节是治疗耐药性的一个关键策略.
- 在立体EEG,网络神经科学和信号处理方面的进步推动了进步.
- 美国病学会 (AES) 2025年研讨会的重点是thalamic神经调节.
研究的目的:
- 总结和整合AES 2025关于发症的乳头神经调节研讨会的见解.
- 呈现专家关于当前证据,争议和未来方向的集体意见.
- 为了突出一个统一的主题,有效的乳头神经调节.
主要方法:
- 展望论文综合了研讨会的演讲.
- 整合科学,技术和临床见解.
- 反映集体小组对证据和未来方向的意见.
主要成果:
- 需要从经验转向患者特定的准.
- 基于 Hodology 的策略至关重要.
- 现场电生理学和网络生物标志物是基础的.
结论:
- 有效的乳头神经调节需要个性化,基于网络的方法.
- 讨论了当前的证据和未来的方向.
- 超越一般化方法对于最佳的患者结果至关重要.
更多相关视频
09:46Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
Published on: March 8, 2015
11.5K
09:49Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala
Published on: June 29, 2022
3.3K
相关概念视频
Epilepsy and Seizures: Overview
1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.1K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
